ArticleOncology letters2026

Androgen receptor drives lenvatinib resistance in hepatocellular carcinoma through transcriptional activation of EIF3I and a downstream ceRNA axis.

Changfeng Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.